PA2G4

Proliferation-associated protein 2G4 · Q9UQ80 · PA2G4 on Sugi Atlas →

0 patent compounds predicted against PA2G4, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to PA2G4 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
A Trial to Assess the Safety and Efficacy of KRN23 in Epidermal Nevus Syndrome (ENS) PHASE4COMPLETED
A Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Immunogenicity of Test Pertuzumab (ZRC-3277, Cadila Healthcare Ltd.,) PHASE3COMPLETED
Anti-CD38 Antibody Treating APS With Thrombocytopenia PHASE2RECRUITING
A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies PHASE1/PHASE2COMPLETED
Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt) PHASE1/PHASE2RECRUITING
Pembrolizumab, Olaparib, Recurrent/Advanced Gastric and Gastro-esophageal Junction(GEJ) Cancer PHASE1/PHASE2RECRUITING
Depletion of Serum Amyloid P Component to Enhance the Immune Response to DNA Vaccination PHASE1/PHASE2COMPLETED
68 Gallium-Fibroblast Activating Protein Inhibitors-46 Positron Emission Tomography - Computerized Tomography for Molecular Assessment of Fibroblast Activation and Risk Assessment in Solid Tumors PHASE2UNKNOWN
Telitacicept in the Treatment of Pediatric IgA Vasculitis-Associated Nephritis nanNOT_YET_RECRUITING
Cardiotoxicity in Metastatic Her 2 Positive Patients Treated With Trastuzumab ,Pertuzumab and Taxanes nanUNKNOWN
Clinical Application of PET Imaging Targeting GPA33 in Malignant Tumors nanNOT_YET_RECRUITING
Patient-derived Glioma Stem Cell Organoids nanACTIVE_NOT_RECRUITING
Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph Nodes nanCOMPLETED
Unravel MGUS (Monoclonal Gammopathy of Unknown Significance) nanUNKNOWN
Genetic Studies of Lysosomal Storage Disorders nanENROLLING_BY_INVITATION
Gastric Cancer Marker Detection and Its Kit Development nanRECRUITING
New Antigens Against Glioblastoma nanNOT_YET_RECRUITING
Molecular Pathway Activation Markers Predicting Efficacy of Trastuzumab Therapy for HER2-positive Breast Cancer nanUNKNOWN
Glycosylation Analysis of Lupus Anti-DNA Antibodies (GALA) nanRECRUITING
Retrospective Study for Diagnosis of Undetected IgG4 Related Diseases in Patients With High Serum IgG4 Levels. nanCOMPLETED
Wound Healing After Tooth Extraction in Individuals With Type 1 Diabetes Mellitus nanUNKNOWN
Genetics and Psychopathology in the 22q11 Deletion Syndrome nanUNKNOWN
Human Epididymis Protein 4 in Endometrial Carcinoma nanCOMPLETED
Amniochorionic Membrane Cells in the Maternal Blood as a Biomarker for Preterm Birth nanCOMPLETED
Biomarkers in Idiopathic Juvenile Arthritis nanUNKNOWN
The Influence of Genetic Variations in ELAPOR1 or ELAPOR2 on Insulin Secretion and Glucose Regulation in Humans nanUNKNOWN
Proteomics to Identify Prognostic Markers After CPR and to Estimate Neurological Outcome nanCOMPLETED
Mechanisms of Diabetic Nephropathy in Ecuador nanSUSPENDED
Genotype-phenotype Correlation in Junctional Epidermolysis Bullosa nanUNKNOWN
Genetic Analysis of Gray Platelet Syndrome nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a PA2G4 binder may also engage these)

ProteinNameSimilarity
P50580 1.000 P50580 →
Q6AYD3 1.000 Q6AYD3 →
Q96327 1.000 Q96327 →
Q09184 0.997 Q09184 →
Q1ZXG4 0.991 Q1ZXG4 →
Q56Y85 0.990 Q56Y85 →
C5DE35 0.990 C5DE35 →
D8PR70 0.990 D8PR70 →
O60085 0.989 O60085 →
O08663 0.989 O08663 →
E5R3Z8 0.987 E5R3Z8 →
Q6CP80 0.987 Q6CP80 →
Q6BVB8 0.986 Q6BVB8 →
C4Y1F8 0.986 C4Y1F8 →
C9SB49 0.986 C9SB49 →
Q55C21 0.985 Q55C21 →
C5M8M4 0.985 C5M8M4 →
E3L3Q8 0.985 E3L3Q8 →
Q0CL94 0.985 Q0CL94 →
A1DA84 0.985 A1DA84 →
D1ZEN1 0.985 D1ZEN1 →
C0SIM8 0.985 C0SIM8 →
B8NA06 0.985 B8NA06 →
A8QBZ2 0.985 A8QBZ2 →
B2B738 0.985 B2B738 →
C5GCN0 0.985 C5GCN0 →
Q5B4X6 0.985 Q5B4X6 →
C1HAB2 0.985 C1HAB2 →
Q9FV49 0.985 Q9FV49 →
M1CZC0 0.984 M1CZC0 →